NCT01958372View on ClinicalTrials.gov

Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 9, 2017

Study Completion Date

November 11, 2019

Conditions
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung CancerLarge Cell Lung CancerRecurrent Non-small Cell Lung CancerSquamous Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Interventions
DIETARY_SUPPLEMENT

soy isoflavones

Given PO

DRUG

cisplatin

Given IV

DRUG

etoposide

Given IV

DRUG

pemetrexed disodium

Given IV

RADIATION

radiation therapy

Undergo RT

Trial Locations (5)

48201

Barbara Ann Karmanos Cancer Institute, Detroit

48446

Karmanos Cancer Institute at McLaren Lapeer Region, Lapeer

48706

Karmanos Cancer Institute at McLaren Bay Region, Bay City

48858

Karmanos Cancer Institute at McLaren Central Michigan, Mount Pleasant

49770

Karmanos Cancer Institute at McLaren Northern, Petoskey

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT01958372 - Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter